Comparing Titan Medical (NASDAQ:TMDIF) & Biostage (OTCMKTS:BSTG)

Titan Medical (NASDAQ:TMDIFGet Free Report) and Biostage (OTCMKTS:BSTGGet Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

Insider & Institutional Ownership

0.0% of Titan Medical shares are held by institutional investors. 0.0% of Titan Medical shares are held by insiders. Comparatively, 15.3% of Biostage shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Titan Medical and Biostage”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Titan Medical $17.63 million 2.13 $6.95 million $0.05 6.60
Biostage N/A N/A -$6.07 million ($0.58) -7.67

Titan Medical has higher revenue and earnings than Biostage. Biostage is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Titan Medical has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Comparatively, Biostage has a beta of -1.02, meaning that its share price is 202% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings for Titan Medical and Biostage, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Titan Medical 0 0 0 0 0.00
Biostage 0 0 1 0 3.00

Profitability

This table compares Titan Medical and Biostage’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Titan Medical N/A -82.31% -51.47%
Biostage N/A N/A -174.43%

Summary

Titan Medical beats Biostage on 7 of the 11 factors compared between the two stocks.

About Titan Medical

(Get Free Report)

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.

About Biostage

(Get Free Report)

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs, as well as product candidates to treat cancer, injury, and birth defects of the bronchus. Its lead product candidate is Biostage Esophageal Implant for the treatment of severe esophageal disease. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.

Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.